Polar Asset Management Partners’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,389
| Closed | -$497K | – | 588 |
|
|
2025
Q1 | $497K | Sell |
27,389
-110,161
| -80% | -$2M | 0.01% | 287 |
|
|
2024
Q4 | $3.48M | Buy |
137,550
+127,850
| +1,318% | +$3.23M | 0.04% | 246 |
|
|
2024
Q3 | $330K | Sell |
9,700
-1,900
| -16% | -$64.6K | 0.01% | 455 |
|
|
2024
Q2 | $429K | Buy |
11,600
+1,800
| +18% | +$66.6K | 0.01% | 412 |
|
|
2024
Q1 | $411K | Sell |
9,800
-84,500
| -90% | -$3.55M | 0.01% | 456 |
|
|
2023
Q4 | $3.74M | Sell |
94,300
-38,100
| -29% | -$1.51M | 0.06% | 237 |
|
|
2023
Q3 | $3.64M | Buy |
+132,400
| New | +$3.64M | 0.08% | 268 |
|
|
2022
Q3 | – | Sell |
-98,600
| Closed | -$2.66M | – | 1358 |
|
|
2022
Q2 | $2.66M | Buy |
98,600
+29,400
| +42% | +$793K | 0.03% | 600 |
|
|
2022
Q1 | $2.36M | Buy |
+69,200
| New | +$2.36M | 0.03% | 574 |
|